Related references
Note: Only part of the references are listed.Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity
Eric M. Tam et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sezary syndrome
H. Torrey et al.
LEUKEMIA (2019)
Structural principles of tumor necrosis factor superfamily signaling
Eva S. Vanamee et al.
SCIENCE SIGNALING (2018)
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer
Yingjie Nie et al.
SCIENCE SIGNALING (2018)
Structural principles of tumor necrosis factor superfamily signaling
Eva S. Vanamee et al.
SCIENCE SIGNALING (2018)
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer
Yingjie Nie et al.
SCIENCE SIGNALING (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis
Rajeev K. Shrimali et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40
David J. Messenheimer et al.
CLINICAL CANCER RESEARCH (2017)
Low intratumoral regulatory T cells and high peritumoral CD8+ T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy
Li Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+Tregs : a systematic review and meta-analysis
Jiafeng Shou et al.
BMC CANCER (2016)
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Junzo Hamanishi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2
Alexander Ungewickell et al.
NATURE GENETICS (2015)
OX40-and CD27-Mediated Costimulation Synergizes with Anti-PD-L1 Blockade by Forcing Exhausted CD8+ T Cells To Exit Quiescence
Sarah L. Buchan et al.
JOURNAL OF IMMUNOLOGY (2015)
Transmembrane TNF-α Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2
Xin Hu et al.
JOURNAL OF IMMUNOLOGY (2014)
Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+Tregs within the tumor microenvironment
Chindu Govindaraj et al.
CLINICAL IMMUNOLOGY (2013)
Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer
Yung-Chang Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2
Yoshiaki Okubo et al.
SCIENTIFIC REPORTS (2013)
Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells
Hiroyuki Tao et al.
LUNG CANCER (2012)
Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood
Xin Chen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism
Liqin Ban et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)